CN Patent

CN103476770B — 阿法替尼盐和多晶型物

Assigned to Ratiopharm GmbH · Expires 2017-02-15 · 9y expired

What this patent protects

本申请中描述阿法替尼盐和其结晶形式以及其制备方法。本申请中还描述阿法替尼的结晶形式和其制备的方法。本发明还包括这些阿法替尼盐和其结晶形式或阿法替尼的结晶形式的药用组合物，它们的制备方法及其在治疗需要其的患者中的用途。

USPTO Abstract

本申请中描述阿法替尼盐和其结晶形式以及其制备方法。本申请中还描述阿法替尼的结晶形式和其制备的方法。本发明还包括这些阿法替尼盐和其结晶形式或阿法替尼的结晶形式的药用组合物，它们的制备方法及其在治疗需要其的患者中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103476770B
Jurisdiction
CN
Classification
—
Expires
2017-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.